Home » Topics » Regulatory

Regulatory
RSS

Remicade granted priority review as Crohn's disease monotherapy

March 25, 2002

Label change for Xenical cleared by CPMP

March 25, 2002

FDA approval for Avinza for once-daily treatment of chronic pain

March 22, 2002

Health Canada approves expanded label for ProstaScint

March 20, 2002

FDA approval for new formulation of Visicol

March 18, 2002

Risperdal approved for delaying schizophrenia relapse in U.S.

March 15, 2002

Extended-release Zerit has similar virological activity to immediate-release drug

March 15, 2002

CPMP recommends approval of irbesartan in diabetic renal disease

March 13, 2002

CPMP recommends approval of Avonex in early-stage MS

March 11, 2002

CPMP recommends expansion of desloratadine indication to indoor and outdoor allergies

March 8, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 1, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...